Senior Manager/Director Clinical Operations
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
The Senior Manager/Director Clinical Operations will be responsible for oversight and management of up to 2 early phase clinical programs in collaboration with the selected Clinical Research Organization (CRO).
Primary Responsibilities:
- Create and execute clinical operational strategic plans in line with product strategy and resource allocation.
- Develop study feasibility, cost estimates, input into contracts, work/change orders and analyze tools and processes to support outsourcing efforts.
- Track clinical program study finances and monthly accruals and review/approve associated clinical site and vendor invoices.
- Build, develop and train internal staff and external vendors, structure department for enhancing efficiency, and create a highly engaged work environment for attracting and retaining highly qualified clinical operations professionals.
- Develop and ensure compliance with SOPs and guidelines, FDA regulations and current ICH GCP guidelines.
- Oversee and maintain the relationships with Contract Research Organizations, vendors, and investigative sites.
- Participate on clinical operations and study team meetings.
- Maintain a high level of professional expertise through familiarity of clinical literature, knowledge of therapeutic area, current medical practice and pharmaceutical regulations.
Additional Expectations
- Although a remote position, it may be necessary to travel to corporate headquarters up to 2 times per year.
- Ability to travel to clinical sites or to the CRO, as necessary to support trial management.
Qualifications:
- B.A/B.S required; M.S., PhD, PharmD, MD or other related advanced scientific degree strongly preferred.
- Minimum of 7 years for manager and 12 years for director level with progressive advancement within clinical operations in the pharmaceutical/biotech industry.
- Flexible and dynamic interpersonal approach, entrepreneurial by nature, a collaborative team player who works well with physicians, scientists, managers, peers, and staff.
- Ability to manage in a consensus environment through teamwork, trust and shared expectations, influencing strategic direction of complex global clinical operations issues, solicit information, listen well, persuade others, make important decisions and shape outcomes.
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
Explore Top Companies in this Space
Freenome
Biotechnology & Liquid Biopsy / AI Multiomics Oncology / Multi-Cancer Early Detection Diagnostics
Apogeetherapeutics
Biotechnology
Apogee Therapeutics
Biotechnology
Xenon Pharmaceuticals
Biotechnology & Pharmaceutical R&D / Neuroscience & Ion Channel Science / Clinical-Stage Drug Development / Genomic-Driven Therapeutics
Lycia Therapeutics
View Company ProfileLycia Therapeutics (operating under lyciatx.com) is a pioneering, clinical-stage biotechnology company developing a novel class of extracellular protein degraders to target and eliminate the root causes of autoimmune diseases, inflammatory disorders, and cancer. Founded in 2019 based on ground-breaking research from Stanford University professor and 2022 Nobel Laureate in Chemistry Dr. Carolyn Bertozzi, the company is operationalizing the field of Bioorthogonal Chemistry into a proprietary drug discovery engine. Lycia's technological framework centers on Lysosomal Targeting Chimeras (LYTACs)—modular, bifunctional molecules engineered to catch pathogenic, circulating, or membrane-bound proteins outside the cell and selectively redirect them into the cellular lysosome for systematic degradation. By capturing extracellular drivers that are traditionally deemed "undruggable" by conventional small molecule inhibitors or standard monoclonal antibodies, Lycia is building a deep therapeutic pipeline to address significant unmet clinical needs. Backed by elite life science institutional venture funds including Versant Ventures, Venrock, and corporate strategics like Eli Lilly, the company has raised over $330M in total capital, including a $75 million Series D round in mid-2026 to accelerate its pre-clinical candidates into human clinical trials. Led by President and CEO Dr. Aetna Wun Trombley, Lycia Therapeutics operates from its advanced research facilities in South San Francisco, California, leading the charge in therapeutic targeted degradation platforms.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.
